|
Market Closed -
Xetra
11:35:23 2026-08-28 am EDT
|
5-day change | 1st Jan Change | ||
| 140.25 EUR | +0.11% |
|
+1.67% | +14.40% |
| Aug. 20 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| Aug. 20 | Cancer vaccines finally garner the spotlight |  |
| Market Cap | 60.98B 70.76B 57.17B 52.19B 98.32B 6,763B 98.63B 678B 265B 3,414B 266B 260B 11,320B | P/E 2026 * |
23.5x | P/E 2027 * | 20.7x |
|---|---|---|---|---|---|
| Enterprise Value | 68.72B 79.74B 64.43B 58.81B 111B 7,621B 111B 764B 298B 3,847B 299B 293B 12,757B | EV / Sales 2026 * |
3.2x | EV / Sales 2027 * | 2.95x |
| Free-Float |
29.73% | Yield 2026 * |
1.68% | Yield 2027 * | 1.72% |
Last Transcript : Merck KGaA
| Aug. 20 | Cancer vaccines finally garner the spotlight | |
| Aug. 20 | UBS Downgrades Merck KGaA to Neutral Rating | MT |
| Aug. 20 | Merck KGaA : Downgraded to Neutral by UBS | ZD |
| Aug. 20 | UBS cuts Merck KGaA to 'Neutral': target €150 | DP |
| Aug. 19 | Kepler Cheuvreux Keeps Merck KGaA at Buy, Raises PT | MT |
| 1 day | +0.11% | ||
| 1 week | +1.67% | ||
| Current month | -2.03% | ||
| 1 month | -3.34% | ||
| 3 months | +7.18% | ||
| 6 months | +9.31% | ||
| Current year | +14.40% |
| 1 week | 137.4 |  | 140.75 |
| 1 month | 134.95 | | 148.8 |
| Current year | 100.7 | | 148.8 |
| 1 year | 100.7 | | 148.8 |
| 3 years | 100.7 | | 177 |
| 5 years | 100.7 | | 231.5 |
| 10 years | 74.54 | | 231.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kai Beckmann
CEO | Chief Executive Officer | 60 | 2026-04-30 |
| Director of Finance/CFO | 56 | 2023-06-30 | |
Gangolf Schrimpf
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Christian Raabe
BRD | Director/Board Member | 62 | 2019-04-25 |
Dietmar Oeter
BRD | Director/Board Member | 59 | 2014-05-08 |
Alexander Putz
BRD | Director/Board Member | 49 | 2020-05-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/25/26 | Buy | Chief Executive Officer | 3,386 | 0.0026% | ||
| 3/25/26 | Buy | Chief Financial Officer | 4,563 | 0.0035% | ||
| 3/27/25 | Buy | 1,401 | 0.0011% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.11% | +1.67% | +29.50% | -14.59% | 70.76B | |
| -0.80% | -2.75% | +76.36% | +34.88% | 366B | |
| -1.47% | -2.61% | +44.02% | +144.43% | 11.96B | |
| +1.74% | +3.38% | +4.66% | +0.32% | 8.72B | |
| 0.00% | +5.14% | -10.75% | +2.56% | 5B | |
| +2.66% | +3.16% | -25.20% | +22.62% | 4.59B | |
| -1.79% | -1.23% | -28.47% | +3.73% | 3.16B | |
| -1.04% | -4.62% | -3.08% | +38.12% | 2.54B | |
| -5.18% | -1.51% | -16.06% | -11.49% | 2.08B | |
| +0.35% | +2.36% | -22.75% | -14.93% | 1.73B | |
| Average | -0.54% | +0.59% | +4.82% | +20.57% | 47.65B | |
| Weighted average by Cap. | -0.62% | -1.82% | +63.50% | +28.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.5B 24.95B 20.16B 18.4B 34.66B 2,384B 34.77B 239B 93.3B 1,204B 93.66B 91.63B 3,991B | 22.61B 26.23B 21.19B 19.35B 36.45B 2,507B 36.56B 251B 98.11B 1,266B 98.49B 96.35B 4,197B |
| Net income | 2.55B 2.96B 2.39B 2.18B 4.11B 283B 4.13B 28.38B 11.07B 143B 11.11B 10.87B 474B | 2.87B 3.33B 2.69B 2.45B 4.62B 318B 4.64B 31.88B 12.44B 160B 12.49B 12.21B 532B |
| Net Debt | 7.74B 8.98B 7.26B 6.62B 12.48B 858B 12.52B 86.08B 33.58B 433B 33.72B 32.98B 1,437B | 5.82B 6.75B 5.45B 4.98B 9.38B 645B 9.41B 64.69B 25.24B 326B 25.34B 24.79B 1,080B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | €140.25 | +0.11% | 177,555 |
| 26-08-27 | €140.10 | +1.05% | 215,095 |
| 26-08-26 | €138.65 | -0.50% | 112,448 |
| 26-08-25 | €139.35 | +0.69% | 171,245 |
| 26-08-24 | €138.40 | +0.33% | 233,461 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRK Stock
Select your edition
All financial news and data tailored to specific country editions
